Your molecules are ready for the next phase. Is your infrastructure ready too? Biotech companies, R&D organizations, and smaller CDMOs often face the same question: How do you translate process risks into a facility that operates robustly and remains easily qualifiable? Building a lab or cleanroom is one thing. Tailoring the space to your product, your process, and your growth path requires a different approach. Ingenium makes that translation a reality—from process requirements and spatial design to HVAC, utilities, monitoring, implementation, and qualification. The result is an environment that fits your product, your process, and your growth path—and one that you can demonstrably keep under control.
The regulations describe what you need to control. The design determines how you implement that in practice. The crucial translation process goes from process steps to zoning, from zoning to pressure cascade, and from pressure cascade to air flow rates, filtration, materials, flows, and measurement points.
Anyone who makes these decisions without in-house engineering runs the risk of ending up with a facility that seems logical on paper but fails to perform adequately during qualification. Making corrections after completion typically costs more time, money, and flexibility than conducting a thorough conceptual study at the outset.
These terms are often used interchangeably, but they do not describe the same thing.
.png)
In short: a cleanroom is a technical control measure; GMP is a broader quality assurance system. The right solution, therefore, does not start with a desired ISO class, but with the question: what product and contamination risks do we need to control?
For sterile medicinal products, EU GMP Annex 1 serves as the specific reference framework. The current Annex 1 describes, among other things, the principles for contamination control, cleanroom classification, monitoring, and aseptic processes. ISO 14644-1:2015 classifies the air cleanliness of cleanrooms and clean zones based on the concentration of airborne particles.
The frameworks complement each other, but are not interchangeable:
That is why we avoid using the phrase “Grade X is the same as ISO Y” in a design. We specify which class and which GMP grade are required for each room, process step, and condition, and justify that choice in the contamination control strategy and the qualification plan.
Without a process description, batch information, and information on contamination or containment risks, it is difficult to perform a responsible sizing analysis.
A change in flow can affect the entire zoning, lock structure, and HVAC balance.
Ceiling height, utility shafts, roof load, electrical capacity, cooling, and scalability determine what is realistic.
Without predetermined measurement points, test criteria, and as-built documentation, rework is inevitable.
Compressed air, pharmaceutical-grade water, process gases, cooling, emergency power, and automation each have their own design and qualification requirements.
The common thread? The greatest risks of delays usually arise in the first few weeks of a project—long before the first contractor arrives on site.
For each process step, describe the product, volume, batch size, staffing, equipment, open product operations, containment requirements, and growth path.
Match activities to the appropriate environment, GMP level, and ISO classification, where applicable. Detail the pressure cascade, airlocks, and flow rates.
Check the technical volume, air-handling concept, electrical capacity, cooling, maintenance access, and expandability.
Ensure that HVAC, wall systems, finishes, monitoring, utilities, and building management systems are verifiable in the specifications.
Provide measurement points, protocols, alarms, data integrity, a cleaning plan, and as-built documentation.
Are you implementing your project in phases? Start sizing your technical spaces, shafts, and utility capacity now to accommodate your desired growth trajectory. Expanding within a certified environment is more complex than reserving the right space in advance.
• Building, renovating, or renting: An existing pharmaceutical facility can save time, but it may limit your workflow and expansion options.
• Traditional cleanroom, modular design, or isolator technology: the choice affects risk, investment costs, lead time, operator interventions, and flexibility.
• Scope of Phase One: A compact, focused scope can accelerate the path to production—as long as the future growth trajectory has been technically defined.
• Monitoring strategy: Sensors, data logging, alarm management, and trend analysis must be aligned with risk, qualification, and operational control.
A high-performance cleanroom is created at the intersection of process, building, engineering, and quality. Ingenium brings these disciplines together and helps you make decisions before they turn into costly design changes.
From process requirements and zoning concepts to HVAC, utilities, monitoring, procurement, implementation, and qualification: we translate your ambitions into a feasible design that fits your facility, budget, and timeline. In doing so, we take into account the applicable regulatory framework and the expectations of the competent authorities—without suggesting that any single design choice, on its own, guarantees GMP compliance.
Are you planning to build, renovate, or expand a lab, cleanroom, or GMP facility? Request an initial feasibility analysis. We’ll translate your process requirements into a realistic design and investment plan.
*This marketing document provides a design-oriented summary and does not constitute legal or regulatory advice. For sterile medicinal products, the current EU GMP Annex 1 is the primary GMP reference framework; ISO 14644-1:2015 addresses the classification of air cleanliness based on particle concentration. The specific classification, zoning, monitoring, and qualification must be established for each process, product, and facility.
.png)
.png)
